| An approach to using recombinant erythropoietin for neuroprotection in very preterm infants JC Fauchere, C Dame, R Vonthein, B Koller, S Arri, M Wolf, HU Bucher Pediatrics 122 (2), 375-382, 2008 | 199 | 2008 |
| Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age RHV Leuchter, L Gui, A Poncet, C Hagmann, GA Lodygensky, E Martin, ... Jama 312 (8), 817-824, 2014 | 149 | 2014 |
| Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: a randomized clinical trial G Natalucci, B Latal, B Koller, C Rüegger, B Sick, L Held, HU Bucher, ... Jama 315 (19), 2079-2085, 2016 | 128 | 2016 |
| Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants JC Fauchère, BM Koller, A Tschopp, C Dame, C Ruegger, HU Bucher, ... The Journal of pediatrics 167 (1), 52-57. e3, 2015 | 103 | 2015 |
| Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants RL O’Gorman, HU Bucher, U Held, BM Koller, PS Hüppi, CF Hagmann, ... Brain 138 (2), 388-397, 2015 | 98 | 2015 |
| Minimally invasive, imaging guided virtual autopsy compared to conventional autopsy in foetal, newborn and infant cases: study protocol for the paediatric virtual autopsy trial CM Rüegger, C Bartsch, RM Martinez, S Ross, SA Bolliger, B Koller, ... BMC pediatrics 14, 1-5, 2014 | 43 | 2014 |
| Neurodevelopmental outcomes at age 5 years after prophylactic early high-dose recombinant human erythropoietin for neuroprotection in very preterm infants G Natalucci, B Latal, B Koller, C Rüegger, B Sick, L Held, JC Fauchere, ... JAMA 324 (22), 2324-2327, 2020 | 24 | 2020 |
| Functional brain maturation assessed during early life correlates with anatomical brain maturation at term-equivalent age in preterm infants G Natalucci, RHV Leuchter, HU Bucher, B Latal, B Koller, PS Hüppi, ... Pediatric research 74 (1), 68-74, 2013 | 24 | 2013 |
| Interobserver variability in assessment of cranial ultrasound in very preterm infants CF Hagmann, M Halbherr, B Koller, P Wintermark, T Huisman, HU Bucher, ... Journal of neuroradiology 38 (5), 291-297, 2011 | 19 | 2011 |
| Evaluation of a simple method for minimizing iatrogenic blood loss from discard volumes in critically ill newborns and children M Weiss, J Fischer, M Boeckmann, O Rohrer, Brigitte and Bänziger Neonatal And Pediatric Intensive Care 27 (6), 1064-1072, 2001 | 11 | 2001 |
| Mental development is associated with cortical connectivity of the ventral and nonspecific thalamus of preterm newborns A Jakab, G Natalucci, B Koller, R Tuura, C Rüegger, C Hagmann Brain and behavior 10 (10), e01786, 2020 | 9 | 2020 |
| Swiss EPONTG; Swiss EPO Neuroprotection Trial Group (2016) Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental … G Natalucci, B Latal, B Koller, C Rüegger, B Sick, L Held, HU Bucher, ... Jama 315, 2079-2085, 0 | 9 | |
| Swiss EPO Neuroprotection Trial Group Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants RL O'Gorman, HU Bucher, U Held, BM Koller, PS Hüppi, CF Hagmann Brain 138 (2), 388-397, 2015 | 8 | 2015 |
| Swiss Erythropoietin Neuroprotection Trial Group: Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants JC Fauchère, BM Koller, A Tschopp, C Dame, C Ruegger, HU Bucher J Pediatr 167, 52-7, 2015 | 7 | 2015 |
| Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates C Dame, J Langer, BM Koller, JC Fauchère, HU Bucher Neonatology 102 (3), 172-177, 2012 | 7 | 2012 |
| Placebo by proxy in neonatal randomized controlled trials: does it matter? TL Burkart, A Kraus, B Koller, G Natalucci, B Latal, JC Fauchère, ... Children 4 (6), 43, 2017 | 4 | 2017 |
| Randomized controlled trials in very preterm infants: does inclusion in the study result in any long-term benefit? CM Rüegger, A Kraus, B Koller, G Natalucci, B Latal, E Waldesbühl, ... Neonatology 106 (2), 114-119, 2014 | 4 | 2014 |
| 56 Safety of High-Dose Erythopoietin for Neuroprotection in Preterm Infants JC Fauchere, BM Koller, A Tschopp, HU Bucher Archives of Disease in Childhood 97 (Suppl 2), A16-A16, 2012 | 2 | 2012 |
| Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized … E Picotti, T Reinelt, B Koller, HU Bucher, CM Rüegger, JC Fauchère, ... JAMA Network Open 5 (12), e2245499-e2245499, 2022 | 1 | 2022 |
| Neurodevelopmental outcome at preschool age after early high-dose recombinant human erythropoietin in very preterm born children: results of a randomized, placebo-controlled … G Natalucci, B Latal, BM Koller, C Ruegger, B Sick, L Held, HU Bucher, ... PEDIATRIC RESEARCH 86, 48-48, 2019 | 1 | 2019 |
